ClinicalTrials.govpublic full text
Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens
multiple myeloma, relapsed, refractory, bortezomib, subcutaneous, oncotherapeutics, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857797
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.